Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-17 Sale |
2025-01-22 6:02 pm |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
15,936 | $11.2 | $178,501 | 243,349 (Indirect Direct) |
View |
| 2024-07-10 Sale |
2024-07-12 6:41 pm |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
9,900 | $11.56 | $114,444 | 259,285 (Indirect Direct) |
View |
| 2024-01-17 Sale |
2024-01-19 5:19 pm |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
9,786 | $17.23 | $168,613 | 216,860 (Indirect Direct) |
View |
| 2023-08-03 Sale |
2023-08-07 8:50 pm |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
34,919 | $20.01 | $698,581 | 298,171 (Indirect Direct) |
View |
| 2023-07-17 Sale |
2023-07-19 8:26 pm |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
17,937 | $18.01 | $323,029 | 250,974 (Indirect Direct) |
View |
| 2023-03-30 Sale |
2023-04-03 6:51 pm |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
9,036 | $26.52 | $239,643 | 233,755 (Indirect Direct) |
View |
| 2022-12-20 Sale |
2022-12-21 9:32 pm |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
8,748 | $19.1 | $167,108 | 169,982 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-23 Option Award |
2025-01-27 6:07 pm |
N/A 2035-01-23 |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
120,450 | $0 | 363,799 (Direct) |
View |
| 2024-07-09 Option Award |
2024-07-11 4:58 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
19,337 | $0 | 269,185 (Direct) |
View |
| 2024-01-23 Option Award |
2024-01-24 4:57 pm |
N/A 2034-01-23 |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
94,500 | $0 | 311,360 (Direct) |
View |
| 2023-08-03 Exercise |
2023-08-07 8:50 pm |
N/A 2028-03-31 |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
10,591 | $0 | 298,171 (Direct) |
View |
| 2023-08-03 Exercise |
2023-08-07 8:50 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
10,591 | $2.08 | 298,171 (Direct) |
View |
| 2023-07-14 Option Award |
2023-07-18 7:19 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
35,156 | $0 | 268,911 (Direct) |
View |
| 2023-03-29 Option Award |
2023-03-31 5:59 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
17,578 | $0 | 242,791 (Direct) |
View |
| 2023-01-25 Option Award |
2023-01-27 7:15 pm |
N/A 2033-01-24 |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
130,200 | $0 | 300,182 (Direct) |
View |
| 2022-12-19 Option Award |
2022-12-21 9:32 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
17,578 | $0 | 169,982 (Direct) |
View |
| 2022-01-26 Option Award |
2022-02-02 8:14 pm |
N/A 2032-01-25 |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
112,500 | $0 | 112,500 (Direct) |
View |
| 2021-05-26 Exercise |
2021-05-28 7:58 pm |
N/A 2029-01-23 |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
4,500 | $0 | 170,016 (Direct) |
View |
| 2021-05-26 Exercise |
2021-05-28 7:58 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
4,500 | $2.08 | 170,016 (Direct) |
View |
| 2021-01-23 Option Award |
2021-01-26 8:00 pm |
N/A 2031-01-22 |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
62,250 | $0 | 62,250 (Direct) |
View |
| 2020-12-30 Exercise |
2021-01-04 8:00 pm |
N/A 2029-01-23 |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
3,500 | $0 | 170,016 (Direct) |
View |
| 2020-12-30 Exercise |
2021-01-04 8:00 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
3,500 | $2.08 | 170,016 (Direct) |
View |
| 2020-06-05 Conversion |
2020-06-09 9:24 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
72,541 | $0 | 246,711 (Direct) |
View |
| 2020-02-28 Option Award |
2020-06-09 9:24 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
27,322 | $13.08 | 246,711 (Indirect) |
View |
| 2020-03-31 Option Award |
2020-06-09 9:24 pm |
N/A 2030-03-30 |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
70,352 | $0 | 246,711 (Direct) |
View |
Ownership |
2020-06-02 9:03 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
0 | $0 | 282,326 (Direct) |
View |